Photoacoustic imaging (PAI) is a promising hybrid imaging technique for biomedical applications, combining optical contrast and acoustic resolution.1 PAI provides anatomical and functional information based on strong optical absorption sensitivity.1 – 3 The optimization of the wavelength according to the target molecule can enhance the selectivity of the visualization of target organs and allows for the extension into functional PAI such as multispectral imaging.4,5 Typically, in the ultraviolet region (10 to 400 nm), the imaging of cell nuclei is performed utilizing the strong absorption by DNA and RNA at wavelengths of .6 In the visible (VIS) region (400 to 700 nm), vascular imaging is typically performed using wavelengths of around 532 nm.7 In the first window of the near-infrared region (NIR-I, 700 to 1000 nm), previous research has achieved relatively deep vascular imaging by taking advantage of the low light attenuation.8 Additionally, to delineate transparent organs such as lymph nodes, gastrointestinal tracts, and bladders, labeled imaging has also been performed using several contrast agents, such as indocyanine green or methylene blue.9 – 12 The second window of the NIR (NIR-II) region, also called short-wave infrared region (SWIR, defined here as 1100 to 2000 nm), is of current interest due to the relative low levels of scattering and the high-maximum permissible exposure compared with the NIR-I region.12 – 15 Additionally, in the SWIR band, we find the optical absorption peaks of water, collagen, and lipids, three major molecules of human tissues.15 – 17